Anteris Technologies Global/$AVR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Anteris Technologies Global
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.
Ticker
$AVR
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Toowong, Australia
Employees
136
ISIN
US03675P1021
Website
AVR Metrics
BasicAdvanced
$144M
-
-$3.30
0.29
-
Price and volume
Market cap
$144M
Beta
0.29
52-week high
$8.36
52-week low
$2.34
Average daily volume
203K
Financial strength
Current ratio
3.673
Quick ratio
3.516
Long term debt to equity
1.311
Total debt to equity
4.685
Interest coverage (TTM)
-158.09%
Profitability
EBITDA (TTM)
-80.802
Gross margin (TTM)
53.03%
Net profit margin (TTM)
-3,281.39%
Operating margin (TTM)
-3,303.93%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on equity (TTM)
-263.65%
Valuation
Price to revenue (TTM)
39.367
Price to book
5.1
Price to tangible book (TTM)
5.12
Price to free cash flow (TTM)
-1.451
Free cash flow yield (TTM)
-68.93%
Free cash flow per share (TTM)
-272.97%
Growth
Revenue change (TTM)
-8.85%
Earnings per share change (TTM)
2.56%
3-year revenue growth (CAGR)
-18.73%
3-year earnings per share growth (CAGR)
18.16%
AVR News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Anteris Technologies Global stock?
Anteris Technologies Global (AVR) has a market cap of $144M as of June 27, 2025.
What is the P/E ratio for Anteris Technologies Global stock?
The price to earnings (P/E) ratio for Anteris Technologies Global (AVR) stock is 0 as of June 27, 2025.
Does Anteris Technologies Global stock pay dividends?
No, Anteris Technologies Global (AVR) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Anteris Technologies Global dividend payment date?
Anteris Technologies Global (AVR) stock does not pay dividends to its shareholders.
What is the beta indicator for Anteris Technologies Global?
Anteris Technologies Global (AVR) has a beta rating of 0.29. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.